CA2083683A1 - Formulation stable a base de sel d'analapril; methode de preparation et utilisation - Google Patents

Formulation stable a base de sel d'analapril; methode de preparation et utilisation

Info

Publication number
CA2083683A1
CA2083683A1 CA2083683A CA2083683A CA2083683A1 CA 2083683 A1 CA2083683 A1 CA 2083683A1 CA 2083683 A CA2083683 A CA 2083683A CA 2083683 A CA2083683 A CA 2083683A CA 2083683 A1 CA2083683 A1 CA 2083683A1
Authority
CA
Canada
Prior art keywords
formula
salt
sodium
stable formulation
analapril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2083683A
Other languages
English (en)
Other versions
CA2083683C (fr
Inventor
Marjo Merslavic
Jozica Razen
Ales Rotar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KRKA dd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25555813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2083683(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2083683A1 publication Critical patent/CA2083683A1/fr
Application granted granted Critical
Publication of CA2083683C publication Critical patent/CA2083683C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CA002083683A 1991-11-25 1992-11-24 Formulation stable a base de sel d'analapril; methode de preparation et utilisation Expired - Fee Related CA2083683C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
YU184291A YU48602B (sh) 1991-11-25 1991-11-25 Postupak za dobijanje stabilne formulacije soli enalaprila
YUP-1842/91 1991-11-25

Publications (2)

Publication Number Publication Date
CA2083683A1 true CA2083683A1 (fr) 1993-05-26
CA2083683C CA2083683C (fr) 2000-09-05

Family

ID=25555813

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002083683A Expired - Fee Related CA2083683C (fr) 1991-11-25 1992-11-24 Formulation stable a base de sel d'analapril; methode de preparation et utilisation

Country Status (11)

Country Link
US (1) US5350582A (fr)
EP (1) EP0545194B1 (fr)
AT (1) ATE150650T1 (fr)
CA (1) CA2083683C (fr)
DE (1) DE69218557T2 (fr)
DK (1) DK0545194T3 (fr)
ES (1) ES2101004T3 (fr)
GR (1) GR3023655T3 (fr)
HR (1) HRP921482B1 (fr)
SI (1) SI9111842A (fr)
YU (1) YU48602B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2128199C (fr) * 1994-07-15 1997-02-04 Bernard Charles Sherman Compositions pharmaceutiques, solides, stables, renfermant du maleate d'enalapril
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
GB9521781D0 (en) * 1995-10-24 1996-01-03 Merck Sharp & Dohme Therapeutic agents
ES2125198B1 (es) * 1997-05-13 1999-11-16 Vita Invest Sa Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.
CA2302832A1 (fr) * 1998-07-21 2000-02-03 Kaneka Corporation Procede de cristallisation d'un sel d'acide maleique de n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline
NZ333206A (en) 1998-12-08 2000-07-28 Bernard Charles Sherman Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
US6637359B1 (en) * 1998-12-15 2003-10-28 Maritrans Inc. System and method for internally fitting a new inner hull to an existing outer hull to form a rebuilt double hull vessel
US6764694B1 (en) * 1999-08-31 2004-07-20 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US6555551B1 (en) 1999-08-31 2003-04-29 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US20040157911A1 (en) * 1999-08-31 2004-08-12 Spiridon Spireas Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
US20030225124A1 (en) * 1999-08-31 2003-12-04 Spiridon Spireas Stable formulations of ACE inhibitors, and methods for preparation thereof
HU226950B1 (en) * 1999-11-03 2010-03-29 Richter Gedeon Nyrt The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
JP4948392B2 (ja) * 2004-03-29 2012-06-06 レ ラボラトア セルビエ 固形薬学的組成物を調製するためのプロセス
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
RS53324B (en) 2005-11-17 2014-10-31 Silverstone Pharma Est. STABLE FORMULATION OF AMORPHIC SALES OF PERINDOPRIL, PROCEDURE FOR THEIR PREPARATION, IN PARTICULAR INDUSTRIAL PREPARATION, AND THEIR USE IN HYPERTENSION THERAPY
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
WO2011161223A2 (fr) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Formes pharmaceutiques à usage oral comprenant de la lercanidipine et de l'énalapril et leurs sels pharmaceutiquement acceptables
EP2654729B1 (fr) 2010-12-24 2016-05-04 KRKA, d.d., Novo mesto Formes pharmaceutiques orales homogènes comprenant de la lercanidipine et de l'énalapril ou leurs sels pharmaceutiquement acceptables ainsi qu'un acide organique
CA2922536C (fr) 2013-08-28 2022-05-03 Psychemedics Corporation Test d'integrite d'echantillons de cheveux
RS58120B1 (sr) 2014-07-31 2019-02-28 Pharmathen Sa Kompozicija orodisperzibilnog filma koja sadrži enalapril za lečenje hipertenzije kod pedijatrijske populacije

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
EP0391462A1 (fr) * 1989-04-05 1990-10-10 Janssen Pharmaceutica N.V. Combinaisons synergiques à kétanserin

Also Published As

Publication number Publication date
EP0545194A1 (fr) 1993-06-09
GR3023655T3 (en) 1997-09-30
DE69218557D1 (de) 1997-04-30
CA2083683C (fr) 2000-09-05
ATE150650T1 (de) 1997-04-15
HRP921482B1 (en) 2000-04-30
YU184291A (sh) 1994-04-05
DK0545194T3 (da) 1997-07-28
EP0545194B1 (fr) 1997-03-26
HRP921482A2 (en) 1996-12-31
US5350582A (en) 1994-09-27
DE69218557T2 (de) 1997-11-13
YU48602B (sh) 1998-12-23
ES2101004T3 (es) 1997-07-01
SI9111842A (sl) 1998-04-30

Similar Documents

Publication Publication Date Title
CA2083683A1 (fr) Formulation stable a base de sel d'analapril; methode de preparation et utilisation
DE3460577D1 (en) Sodium salt of ursodeoxycholic sulphate
CS144791A3 (en) Novel sulfonyl compounds
CA2138825A1 (fr) Compositions de rincage
CA2047783A1 (fr) Solution stable d'hypochlorite de sodium
ES8308864A1 (es) Procedimiento para la fabricacion de nuevos derivados aminoalcoxi aromaticos.
EP0138616A3 (fr) Nona- et décapeptides pour augmenter l'activité naturelle de destruction de cellules, leurs procédés d'obtention et compositions pharmaceutiques les contenant
AU5188393A (en) 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
HU901193D0 (en) Process for protection against phytopathogenic bacteria using phosphonic acid derivatives
JPS5517319A (en) Preparation of eugenol zinc salt
MY110751A (en) Positive inotropic and lusitropic pyrroloquinolinone derivatives
JPS57188515A (en) Stabilized aqueous dopamine preparation
ES8601209A1 (es) Procedimiento para preparar derivados de 5h-(1)-benzopirano-(2,3-d)pirimidina
ES8403911A1 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
CA2143216A1 (fr) Analogues de la 15-deoxyspergualine, leur preparation et leur utilisation therapeutique
AU6701096A (en) Process for the manufacturing of iodinated contrast agents
ES8506641A1 (es) Procedimiento para preparar 1-acetonil-2-(fenilimino)-imidazolidinas
CA2076772A1 (fr) Nouvelle analogues de la vitamine d3
ES8205219A1 (es) Un metodo para producir un compuesto de hidrouracilo
ES8501380A1 (es) Un procedimiento para preparar l-tiazolidin-4-carboxilato de zinc
IL71068A0 (en) N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it
ES8504829A1 (es) Un procedimiento para la preparacion de un acido -hidroxietilfosfinico
EP0364928A3 (fr) Composition de pâte de dentifrice
DE69608260D1 (en) Wässrige spectinomycinborat-auflösung
ES8500266A1 (es) "procedimiento para la preparacion de nuevos acidos benzoilparabanicos"

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed